1 completed, 1 not yet recruiting, 1 recruiting. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow ANCA-Associated Vasculitis: new trials by email Literature Review of ANCA-Associated Vasculitis trials Research Report on ANCA-Associated Vasculitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases universal allogeneic anti-CD19/BCMA CAR T-cells - Systemic Lupus Erythematosus, Autoimmune Hemolytic Anemia | Phase 1 | Not yet recruiting | Changzhou No.2 People's Hospital | 18 | 2025-05-01 | 2025-05-18 |
| The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases FKC289 - Lupus Nephritis, ANCA-associated Vasculitis | Phase 1 | Recruiting | Nanjing University School of Medicine | 24 | 2024-03-04 | 2026-07-06 |
| Efficacy and Safety of Substitution of Glucocorticoid for BDB-001 Injection in Patients With Anti-neutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis BDB-001 injection, Cyclophosphamide, Glucocorticoids - ANCA-associated Vasculitis | Phase 1 / Phase 2 | Completed | Staidson (Beijing) Biopharmaceuticals Co., Ltd | 93 | 2022-02-22 | 2025-08-07 |
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (3) · Immunoglobulin G4-Related Disease (2) · Anemia, Hemolytic, Autoimmune (1) · Lupus Erythematosus, Systemic (1) · Lupus Nephritis (1) · Myasthenia Gravis (1) · Myositis (1) · Scleroderma, Systemic (1)
Autoimmune Diseases (3) · Cardiovascular Diseases (3) · Immune System Diseases (3) · Skin Diseases (3) · Skin Diseases, Vascular (3) · Skin and Connective Tissue Diseases (3) · Systemic Vasculitis (3) · Vascular Diseases (3) · Vasculitis (3) · Connective Tissue Diseases (2) · Anemia (1) · Anemia, Hemolytic (1) · Autoimmune Diseases of the Nervous System (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1)
BDB001 (1) · Cyclophosphamide (1) · Glucocorticoids (1) · Prednisone (1)
Changzhou No.2 People's Hospital (1) · Nanjing University School of Medicine (1) · Staidson (Beijing) Biopharmaceuticals Co., Ltd (1)
China (3)
Minghui Zhao, Postdoc (1) · Zhihong Liu (1)